Image For Activity Cover
Renal Artery Denervation for Treatment of Hypertension
Description

This activity was planned with a goal to understand new developments relating to renal artery denervation as a potential therapy for hypertension.

CME/CNE and MOC Information

Accreditation

Physicians
The American College of Cardiology Foundation (ACCF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The ACCF designates this enduring material for a maximum of up to .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.

Nurses
The ACC is accredited as a provider of continuing nursing education by The American Nurses Credentialing Center's Commission on Accreditation.

The ACC designates this educational activity for a maximum of .25 continuing education hours.

MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to .25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Target Audience

This activity is intended for cardiovascular adult physicians, internists, family physicians, APRNs, and physician assistants.  

Important Dates

Date of Release: November 11, 2020

Term of Approval/Date of CME/CE Expiration: November 11, 2023

 

Learner Objectives

Upon completion of this program, you should be able to:

 

  • Identify certain limitations of medical therapy in the treatment of hypertension.
  • Describe potential shortcomings of previous randomized trials of renal artery denervation for the treatment of hypertension.
  • Discuss the findings of the SPYRAL HTN-OFF MED Pivotal trial of renal artery denervation.
  • Define objectives for further investigation of renal artery denervation therapy.


Method of Participation and CME/CNE Certificate
Requesting AMA PRA Category 1 CME Credit™ and Continuing Education credit for this Activity
To request credit, you must:

  1. Read all text and view all tables and/or figures in the case for which you wish to receive credit.
  2. Answer the questions in each case for which you wish to claim credit. After you have answered all the questions, click on the Exam Summary button. A Claim Credit button will appear on this page if you have achieved a passing score of 70% or better. If you did not achieve a passing score, please click the Reset Scores link and retake the exam.
  3. Click the Claim Credit button and answer the evaluation questions in the pop-up window.
  4. Enter the total amount of time you actually spent in the activity in the box provided. Please note that you may only claim once for each module in this activity. Click Submit.
  5. You will receive a message that your request has been submitted and a link to view your certificate. You may view and download the certificate when you receive the message, you may also view it at any time in the My Transcript section of My ACC.

This CME/CNE-certified activity may contain links to other educational resources such as clinical trial summaries, journal articles, guidelines, etc., that may not be CME/CNE-certified. Please note that clicking on the links provided to view these resources will open new windows, which are outside of this CME/CNE-certified activity.

Authors:
Colin Wright, MD

Janice Opladen, NP

Jennifer Falvey, PharmD, BCPS

Craig Narins, MD

Peer-Reviewers:

Konstantinos D. Boudoulas, MD, FACC

M. Dominique Ashen, PhD, CRNP

Jennifer Host, CNP

Objectives
Learner Objectives
Upon completion of this activity, the learner should be able to:
  • Identify certain limitations of medical therapy in the treatment of hypertension.
  • Describe potential shortcomings of previous randomized trials of renal artery denervation for the treatment of hypertension.
  • Discuss the findings of the SPYRAL HTN-OFF MED Pivotal trial of renal artery denervation.
  • Define objectives for further investigation of renal artery denervation therapy.
Summary
Availability: On-Demand
Available Nov 10, 2020 to Nov 10, 2023
Cost: FREE
Credit Offered: 0.25 CME Credit
0.25 CNE Credit
0.25 ABIM-MOC Point
Powered By